IMMX: Immix Biopharma Inc

IMMX新闻

• Investing 13:41 ImmixBio reports no neurotoxicity in CAR-T therapy for AL amyloidosis
• Investing 11:44 Immix Biopharma stock advances as H.C. Wainwright reiterates Buy rating
• Investing 13:52 Immix Biopharma Attends FDA CEO Forum in Washington DC
• Investing 11:37 H.C. Wainwright reaffirms Immix Biopharma stock Buy rating after trial
• Investing 19:13 immix biopharma enters at-the-market offering agreement
• Investing 19:02 Immix Biopharma reports high response rate in AL Amyloidosis trial
• Investing 18:56 Immix Biopharma stock soars to 52-week high of $2.99
• Investing 13:12 Immix Biopharma accelerates NEXICART-2 trial enrollment
• Benzinga 09:09 Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - 180 Life Sciences (NASDAQ:ATNF), Biodexa Pharmaceuticals (NASDAQ:BDRX)
• Investing 20:08 Immix Biopharma reports promising trial results for NXC-201
• Investing 21:04 Immix Biopharma to Host KOL Event to Discuss NXC-201 Clinical Data Presented at ASCO 2025 in relapsed/refractory AL Amyloidosis